Shanghai RAAS Blood Products financials at a glance

+ Portfolio

The revenue of Shanghai RAAS Blood Products is reported as 7.96396 billion Yuan Renminbi in the fiscal year 2023. The earnings were 0 Yuan Renminbi per share in 2023, which was 33.33 lower than 2016. And about 1.82708 billion Yuan Renminbi are reported as free cash flow in the financials of Shanghai RAAS Blood Products 2023. Dividends of 0.03 Yuan Renminbi per share were paid to shareholders of Shanghai RAAS Blood Products stock SZSE:002252 in fiscal 2023.

Forecast

Financials

Year	Year	TTM	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
Rev.	Revenue	N/A	¥1.93B	¥2.33B	¥2.01B	¥1.32B	¥496.36M	¥662.68M	¥567.39M	¥483.36M	¥387.52M	¥309.86M
GM %	Gross Margin %	41.62%	63.40%	63.70%	61.40%	62.54%	64.69%	59.97%	58.77%	62.86%	57.51%	62.39%
OM	Operating Margin	29.13%	39.63%	47.37%	41.79%	44.07%	36.66%	38.61%	40.16%	43.55%	38.27%	41.19%
EPS	Earnings Per Share	¥0.31	¥0.12	¥0.18	¥0.14	¥0.12	¥0.04	¥0.06	¥0.06	¥0.05	¥0.04	¥0.03
Div.	Dividends	N/A	¥0.02	¥0.03	¥0.03	¥0.00	¥0.01	¥0.00	¥0.04	¥0.00	¥0.00	¥0.04
PR %	Payout Ratio %	0	16.67%	16.67%	21.43%	0	25.00%	0	66.67%	0	0	133.33%
Sha.	Shares	N/AM	4,970.24M	4,692.42M	5,046.33M	4,141.42M	4,199.42M	3,525.12M	3,525.12M	3,525.12M	3,525.12M	3,525.12M
OCF	Operating Cash Flow	N/A	¥264.95M	¥638.22M	¥0.00M	¥0.00M	¥-90.11M	¥263.46M	¥178.03M	¥200.21M	¥0.00M	¥0.00M
FCF	Free Cash Flow	N/A	¥107.11M	¥490.73M	¥0.00M	¥0.00M	¥-,219.79M	¥113.76M	¥1.23M	¥111.00M	¥0.00M	¥0.00M
FCFS	Free Cash Flow Per Share	¥0.30	¥0.02	¥0.10	¥0.12	¥0.10	¥-0.06	¥0.03	¥0.00	¥0.03	¥0.02	¥0.03

Shanghai RAAS Blood Products financials at a glance

Financials

Discover